A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may increase patients’ risk for a dangerous eye condition. The findings about ...

A North Carolina woman has filed a lawsuit in New Jersey federal court, claiming that her use of the diabetes medication Ozempic led to permanent vision loss. Elizabeth Pennell alleges that Novo ...

The researchers tracked nearly 175,000 patients with diabetes who received semaglutide -- the active ingredient in Ozempic ... The higher risk of developing the sight-threatening eye problem ...

Using Ozempic with insulin may increase your risk of this side effect ... cause worsening symptoms of diabetic retinopathy, an eye condition related to diabetes. If you have diabetic retinopathy ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like Ozempic.

open image in gallery Semaglutide - the active ingredient in Ozempic and other Novo products - has been linked to eye conditions (Getty/iStock) In subgroup analyses, the elevated risk for NAION ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may increase patients’ risk for a dangerous eye condition ... the active ingredient in ...